vimarsana.com

Latest Breaking News On - Decentralized procedure - Page 1 : vimarsana.com

AbbVie introduces Produodopa for advanced Parkinson s in EU

AbbVie has announced the launch of Produodopa, a new treatment for advanced Parkinson's disease (PD) patients in the European Union.

AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson s Disease in the European Union

Moberg Pharma´s Interim report January - June 2023

Moberg Pharma´s Interim report January - June 2023MOB-015 IS RECOMMENDED FOR APPROVAL IN 13 EUROPEAN COUNTRIES SIX-MONTH PERIOD (JAN-JUN 2023)·      EBITDA SEK -10.7 million (-9.1)·      Operating profit (EBIT) SEK -12.0 million (-10.4)&middo.

MOB-015 is recommended for approval in EU: Moberg Pharma

/PRNewswire/ Moberg Pharma AB (OMX: MOB) hereby announces that the Decentralized Procedure has ended with a positive outcome and that MOB-015 is recommended.

MOB-015 is recommended for approval in EU

MOB-015 is recommended for approval in EU
realtid.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from realtid.se Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.